查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年压力性尿失禁的全球市场
市场调查报告书
商品编码
1140736

2022-2029 年压力性尿失禁的全球市场

Global Stress Urinary Incontinence Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计压力性尿失禁市场在预测期间（2022-2029 年）将以 6.91% 的复合年增长率增长。

压力性尿失禁 (SUI) 是膀胱和尿道受到突然压力，导致括约肌短时间张开，导致尿液漏出的现象。在轻度 SUI 中，可能会通过突然的剧烈运动（例如锻炼、打喷嚏、大笑或咳嗽）施加压力。压力性尿失禁更为严重，并且可以通过不太有力的运动（例如站立、行走或弯腰）洩漏。泌尿意外只不过是几滴尿液浸入了你的衣服。 SUI 是女性常见的膀胱问题。在男性中较少见。推动压力性尿失禁市场增长的主要因素是世界老年人口的增加和世界慢性病患病率的增加。此外，尿失禁患病率的上升是预计将在未来一段时间内为市场带来显着增长的主要因素。

市场动态。世界老龄化社会的到来推动市场增长

尿失禁是尿液的意外洩漏。虽然它可能发生在任何人身上，但尿失禁在老年人中更为常见，尤其是老年女性。尿失禁通常可以治愈或控制。随着人们年龄的增长，他们的膀胱肌肉、盆底肌肉和其他肌肉会变弱，从而产生可能会刺激尿失禁原因的问题。根据世界卫生组织 2021 年发布的报告，到 2030 年，全球六分之一的人将超过 60 岁。届时，60岁及以上人口将从2020年的10亿增加到2050年的14亿，世界60岁及以上人口将翻一番，达到21亿。这样，老年人失禁的增加是推动未来市场增长的主要因素。

但是，对失禁的低意识是市场增长的障碍。失禁意识低下可能会抑制压力性尿失禁市场的销售增长。此外，与女性尿失禁相关的尿失禁、大便失禁、疼痛、器官穿孔等副作用阻碍了压力性尿失禁市场的销售增长。

市场细分。在预测期内，阴道内装置部分预计将成为市场的主导部分。

根据设备类型，压力性尿失禁市场分为内部尿道设备、内部阴道设备和外部尿道设备。

内部阴道装置部分进一步分为常规装置和定制装置。压力性尿失禁在女性中比男性更常见。当女性分娩或男性前列腺手术导致盆底肌肉和尿道括约肌的力量趋于减弱时，就会发生压力性尿失禁。因此，由于这些因素，阴道内装置有望在市场上占据主导地位。

压力性尿失禁是根据医院、专科诊所和门诊手术中心等最终用户进行细分的。

在最终用户细分市场中，预计医院将占据全球尿失禁设备市场的很大份额，因为在医院接受治疗的许多患者都患有尿失禁。由于该行业的技术进步，预计医院在未来几年也将以最高的复合年增长率增长。

地理渗透。在预测期内，北美将成为主要地区。

该研究按地区分析了全球市场的压力性尿失禁市场，包括北美、欧洲、亚太地区、南美、中东和非洲。

预计北美将在 2021 年主导全球压力性尿失禁市场。预计美国在预测期内将代表北美的大幅增长。由于发达的医疗基础设施和公众对最新医疗发展的高度认识，预计压力性尿失禁在美国将出现增长潜力。预计拉丁美洲在预测期内的价值也将出现显着增长。预计慢性病增加等因素将推动该地区的市场增长。

由于该地区老年人口的增加和医疗基础设施的发展，预计亚太地区压力性尿失禁市场将在预测期内快速增长。

竞争格局。

由于主要食品品牌的存在，压力性尿失禁市场是一个竞争激烈的市场。促进全球市场增长的主要压力性尿失禁参与者是康乐保、波士顿科学公司、C. R. Bard, Inc.、ConvaTec Group Plc、Ethicon, Inc、Caldera Medical Inc、Cook Medical、Covidien plc (Medtronic)、Prosurg、公司和 Cogentix 医疗公司。主要参与者正在为全球压力性尿失禁市场的增长采用新产品发布或扩张策略。一些主要参与者正在遵循合併和合作战略来扩展业务。例如，2022 年 1 月，康乐保 A/S 完成了对 Atos Medical 的收购。此次收购将使 Colopl 的有机收益按固定汇率增长约 7%。通过此次收购，该公司增加了一个新的业务部门，即耳鼻喉科和呼吸系统，作为共享 Colopl 基础设施的独立战略部门运营。 2020 年 11 月，丹麦医疗器械製造商 Colopl 斥资 1.45 亿美元收购了早期公司 Nine Contents Medical，该公司开创了用于治疗膀胱过度活动症的植入式胫神经刺激治疗。 Nine Contents Medical 正在开发一种治疗膀胱过度活动症的创新疗法。购买价格包括预付款和额外的未来里程碑付款。

COVID-19 的影响将对全球压力性尿失禁市场产生负面影响。

COVID-19 的爆发对全球压力性尿失禁市场的增长产生了负面影响。对医院服务的限制影响了尿失禁患者的专业检查和手术治疗。医生和医院工作人员正忙于治疗 Covid 患者。尿失禁患者避免去医院就诊併购买设备以避免污染。因此，COVID-19 大流行抑制了 2020 年压力性尿失禁的市场价值。

全球压力性尿失禁市场报告包含大约 61 个市场数据表、51 个数字，共 170 页。

内容

第1章调查方法及范围

  • 调查方法
  • 调查的目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按设备类型划分的市场细分
  • 按材料类型划分的市场细分
  • 按最终用户划分的市场细分
  • 按地区划分的市场细分

第 4 章全球压力性尿失禁市场动态

  • 影响市场的因素
    • 驱动程序
      • 世界各地的老年人口都在增加。
      • 尿失禁患病率上升
      • 慢性病增加
    • 限制因素
      • 失禁患者群体缺乏认识
      • 与女性尿失禁装置相关的副作用，例如尿失禁、大便失禁、疼痛和器官穿孔。
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 价格分析
  • 监管分析
  • 报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • 市场上 COVID-19 的分析
    • COVID-19 之前的市场情景
    • 当前 COVID-19 市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第 7 章按设备类型

  • 内置尿道装置
  • 外置尿道器械
  • 阴道内器具

第 8 章按材料分类

  • 硅胶
  • 聚氨酯泡沫

第 9 章，最终用户

  • 医院
  • 妇科诊所
  • 门诊手术中心

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章公司简介

  • 康乐保
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务概览
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • ConvaTec Group Plc
  • Ethicon, Inc.
  • Caldera Medical Inc
  • COOK MEDICAL
  • COVIDIEN PLC（MEDTRONIC）
  • PROSURG, INC.
  • Cogentix Medical Inc.（LIST NOT EXHAUSTIVE）
  • Premium Insights

第14章 DataM

简介目录
Product Code: DMPH3132

Market Overview

Stress Urinary Incontinence Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 6.91 % during the forecast period (2022-2029).

Stress Urinary Incontinence (SUI) occurs when urine leaks out with sudden pressure on the bladder and urethra, causing the sphincter muscles to open briefly. With mild SUI, the pressure may come from sudden, forceful activity, such as exercise, sneezing, laughing, or coughing. Stress urinary incontinence is more severe and can leak with less vigorous activities such as standing up, walking, or bending over. Urinary accidents range from a few drops of urine, which is soaked in clothes. SUI is a common bladder problem for women. It happens less frequently in men. The major factors propelling the growth of the stress urinary incontinence market are the rising geriatric population across the globe and the increase in chronic diseases across the globe. Moreover, the Rise in the prevalence of urinary incontinence is the major factor expected to deliver significant growth to the market in the upcoming period.

Market Dynamics: Rising geriatric population worldwide drives market growth

Urinary incontinence means that a person leaks urine by accident. Although it may happen to anyone, urinary incontinence is more common in older people, particularly older women. Incontinence can often be healed or controlled. With the growing age, problems such as weak bladder muscles, pelvic floor muscles and others occur in an older population, hence, stimulating the causes of urinary incontinence. As per the World Health Organization report published in 2021, by 2030, 1 in 6 people in the world will be aged 60years or over. At that timeshare, the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2050, and the world's populations of people aged 60 years and older will double (2.1 billion). Thus, increasing incontinence in the elderly population is the major factor stimulating market growth over the forecast years.

However, a Lack of awareness among the incontinent patient population hampers the market growth. The lack of awareness among the incontinent patient population may reduce revenue growth in the stress urinary incontinence market. In addition, side effects such as urinary and faecal incontinence, pain, and organ perforation associated with female urinary incontinence devices deter revenue growth in the stress urinary incontinence market.

Market Segmentation: The internal vaginal device segment is projected to be the dominant segment in the market during the forecast period.

Based on the device type, the stress urinary incontinence market has been classified into internal urethral devices, internal vaginal devices and external urethral devices.

The internal vaginal devices segment can be further categorized into traditional and custom-made devices. Urinary stress incontinence is significantly more common in women than in men. Stress Urinary Incontinence occurs when pelvic floor muscles or urinary sphincter are likely to lose strength, either due to women's childbirth or men's prostate surgery. Thus, due to such factors, the internal vaginal device is expected to hold a dominant position in the market.

The stress urinary incontinence is segmented based on end-user, which includes hospitals, specialty clinics, and ambulatory surgical centers.

Hospital in the end-user segment is expected to have a significant share of the global market for urinary incontinence devices due to the large patient population treated in hospitals suffering from urinary incontinence. Moreover, Hospitals are also expected to grow with the highest CAGR in the forthcoming period with the rise in technological advancement in the industry.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the stress urinary incontinence market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America will be dominant in the global stress urinary incontinence market in 2021. The U.S. is expected to represent considerable growth in North America during the forecast period. In the U.S., stress urinary incontinence is expected to have potential growth due to its well-developed health care infrastructure and high awareness of the latest medical developments among the people. Moreover, Latin America is expected to represent significant growth in terms of value during the forecast period. Factors such as the rise in chronic diseases are expected to propel regional market growth.

The stress urinary incontinence market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the rise in geriatric population & rising healthcare infrastructure in the region.

Competitive Landscape:

The stress urinary incontinence market is highly competitive, owing to the presence of big food brands. The key Stress Urinary Incontinence players which are contributing to the growth of the global market include Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc, Cook Medical, Covidien plc (Medtronic), Prosurg, Inc., and Cogentix Medical Inc, among others. The major players are adopting new product launches and expansion strategies for global growth in the stress urinary incontinence market. Some key players follow merger and collaboration strategies to expand their business. For instance, in January 2022, Coloplast A/S completed the acquisition of Atos Medical. This acquisition helps to grow the organic revenue of Coloplast by around 7 % at a constant exchange rate. With this acquisition, the company added a new business segment, ENT & Respiratory Care which is run as a separate strategic unit operating on shared Coloplast infrastructure in their portfolio. In November 2020, Coloplast, a danish medical device company, acquired Nine Continents Medical, Inc., an early-stage company pioneering an implantable tibial nerve stimulation treatment for overactive bladder, for USD 145 million. Nine Continents Medical, Inc. develops innovative solutions for the overactive bladder. This acquisition price includes an upfront cash payment and an additional contingent future milestone payment.

COVID-19 Impact: Negative impact on the global stress urinary incontinence market.

The outbreak of COVID-19 has negatively impacted the growth of the stress urinary incontinence market globally. Restrictions on hospital services have affected the specialized investigation and surgical management of patients with urinary incontinence. Doctors and hospital staff is busy in treated Covid patients. Patients with urinary incontinence avoid visits to hospitals and buy devices to avoid contamination. Therefore, the COVID-19 pandemic has hampered the market value of the stress urinary incontinence market in 2020.

The global stress urinary incontinence market report would provide an access to approximately 61 market data tables, 51 figures and 170 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Device type
  • 3.2. Market Snippet by Material Type
  • 3.3. Market Snippet by End user
  • 3.4. Market Snippet by Region

4. Global Stress Urinary Incontinence Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising geriatric population across the globe.
      • 4.1.1.2. Rising prevalence of urinary incontinence
      • 4.1.1.3. Increase in chronic diseases
    • 4.1.2. Restraint
      • 4.1.2.1. lack of awareness among incontinent patient population
      • 4.1.2.2. Side effects such as urinary and fecal incontinence, pain, and organ perforation associated with female urinary incontinence devices.
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type Segment
  • 7.3. Market Attractiveness Index, By Device type Segment
    • 7.3.1. Internal urethral devices
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. External urethral devices
    • 7.3.3. Internal vaginal devices

8. By Material Type

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type Segment
  • 8.3. Market Attractiveness Index, By Material Types channel Segment
    • 8.3.1. Silicone
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Polyurethane Foam

9. By End-user

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user Segment
  • 9.3. Market Attractiveness Index, By End user channel Segment
    • 9.3.1. Hospitals
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Gynecology clinics
    • 9.3.3. Ambulatory surgical centers

10. By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device type
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Coloplast*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Boston Scientific Corporation
  • 12.3. C. R. Bard, Inc.
  • 12.4. ConvaTec Group Plc
  • 12.5. Ethicon, Inc.
  • 12.6. Caldera Medical Inc
  • 12.7. COOK MEDICAL
  • 12.8. COVIDIEN PLC (MEDTRONIC)
  • 12.9. PROSURG, INC.
  • 12.10. Cogentix Medical Inc. (LIST NOT EXHAUSTIVE)
  • 12.13. Premium Insights

14. DataM Intelligence Analysis

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us